Project Grant R01AG089640
Award Date
8/15/24
Completion Date
7/31/29
Dollars Obligated
$832K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
The University of Southern California (USC) was awarded a $826,222 Project Grant from the National Institute on Aging's Aging Research program (CFDA 93.866) to study the role of the cGAS-STING innate immune pathway in neuroinflammation and Alzheimer's disease pathogenesis. The key objectives are to: 1) investigate how cGAS-STING modulates neuroinflammation in cellular models and animal studies; 2) assess the impact of herpes simplex virus (HSV-1) infection on the cGAS-STING pathway and...
This $156,000 Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) supports research by Thomas Jefferson University to develop a novel therapeutic strategy for Alzheimer's disease (AD). The key objectives are to: Generate intrabodies to neutralize RNA::DNA hybrids that activate the cGAS-STING pathway, a mechanism linked to neuroinflammation and cell death in AD cell models. Validate the efficacy of these intrabodies in suppressing...
This Project Grant award, issued by the National Institute on Aging under CFDA 93.866 - Aging Research, aims to elucidate the molecular mechanisms underlying the neurodegenerative reprogramming of microglia, the brain's resident immune cells, in Alzheimer's disease (AD). The $442,357 grant will fund research to determine how cellular stress signaling pathways, specifically the Integrated Stress Response (ISR), epigenetically reprogram microglia in a way that exacerbates their neurodegenerative...
This federal Project Grant award R36AG087310 was provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) to the University of Southern California (USC) in the amount of $103,304. The award, effective August 1, 2024 through July 31, 2025, will support research to identify specific neuron cell types within the medial temporal lobe that are susceptible to Alzheimer's disease (AD) pathology. The project aims to use advanced viral tracing and microscopy...
This federal Project Grant award, provided by the National Institute on Aging under CFDA program 93.866 - Aging Research, supports a research study focused on understanding the mechanisms responsible for autophagy defects in neurons affected by Alzheimer's disease (AD). The $749,030 award, with a performance period from December 15, 2024 to November 30, 2029, will be used by the principal investigator at The Trustees of Columbia University in the City of New York to evaluate the effects of...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to gain a mechanistic understanding of the role of cellular senescence in the pathogenesis of Alzheimer's disease (AD). The $460,625 grant will fund research at the University of Massachusetts Medical School to dissect the separate P53/P21 and P16 senescence pathways and their functional consequences in AD using human induced pluripotent stem cell-based models. The 2-year project will produce...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $378,750 in funding to Saint Louis University to conduct research on the role of cytosolic DNA-induced sterile inflammation in driving cellular and organismal progeria/aging hallmarks. The key objectives are to: 1) define the non-canonical mode of STING stimulation upon progerin-induced accumulation of cytosolic DNA, 2) examine how STING, STAT1, and downstream interferon-stimulated genes like...
This $427,625 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to elucidate the mechanisms by which microgliopathy, a genetic neurological disorder, causes early-onset dementia. The research will investigate how the loss of the DAP12 protein in microglia, the immune cells of the brain, leads to heightened signaling of the RUNX and STAT3 pathways. This dysregulation is hypothesized to disrupt normal microglial functions and induce brain pathology and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $433,125 will fund a study to investigate the relationship between microglia, neurons, and tau pathology in Alzheimer's disease. The research will utilize a novel model system of microglial co-cultures with hippocampal assembloids derived from patient-derived induced pluripotent stem cell (iPSC) lines with MAPT mutations and healthy controls. The goal is to explore how bidirectional changes...
This Project Grant award of $614,424 from the National Institute on Aging (CFDA 93.866 Aging Research program) supports research to illuminate early microglial dysfunction in Alzheimer's disease (AD). The study aims to integrate novel explainable AI techniques with deep learning methods to better define AD-specific microglial states and pathways from single-cell brain data. As proof-of-concept, the researchers will model the combined effects of AD stimuli and neuronal injury on...